Vijaya Diagnost. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Healthcare Services | Market Cap: ₹15.5K Cr
Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets. Vijaya Diagnostic Centre delivered a strong Q1 FY27 with 23% revenue growth and is confident of high double-digit growth for the full year FY27.
From Vijaya Diagnost.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹1,462
Market Cap
₹15.5K Cr
P/E Ratio
82.6
Revenue Rank
Margin Rank
How does Vijaya Diagnost. rank in Healthcare Services?
Compare Vijaya Diagnost. against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
Vijaya Diagnost. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹219 Cr, net profit ₹48 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets.
- →The company expects to sustain high double-digit revenue growth for FY27, building on a strong Q1 growth of 23%.
- →Mid to long-term sustainable revenue growth is targeted around 15% annually over the next 3 to 5 years.
- →Hyderabad cluster, which contributes ~67% of revenue, grew 17% year-on-year despite maturity, indicating strong organic growth.
- →New tier-2 and metro locations like Rajahmundry, Tirupati, Kammam, Bangalore, Pune, and Kolkata are outperforming expectations, often breaking even within 2 quarters.
- →Expansion focus includes dense networks in Pune, Bangalore, and Kolkata with plans to add 15 hubs across these metros over 12 months.
- →Pathology volumes are scaling alongside radiology, supported by integrated offerings leading to higher tests per patient and better wallet share.
- →Corporate wellness programs and retail wellness packages are additional growth drivers across tier-1 and tier-2 cities.
📈 Profitability & Margins
Rank 3- →Vijaya Diagnostic Centre delivered a strong Q1 FY27 with 23% revenue growth and is confident of high double-digit growth for the full year FY27.
- →Mid to long-term sustainable growth is targeted at around 15% annually over 3 to 5 years.
- →The company expects a new normal growth rate of approximately 20% based on successful expansion outside Hyderabad and Andhra clusters.
- →Mature centres grew at 16% in Q1, with new centres contributing 6-6.5% revenue year-on-year.
- →EBITDA margins are expected to be maintained above 40%, despite ongoing expansion and new hubs coming online.
- →Operating leverage in existing clusters supports margin stability even as new hubs scale up.
- →PAT margin held steady at 23% in Q1 FY27, reflecting profitability improvements.
- →Management emphasizes confidence in replicating growth strategies across new clusters and deeper market penetration.
🏗️ Capital Expenditure Plans
Yes- →Planned capex of approximately INR 190 to 195 crores over the next 12 months.
- →Commissioning of 9 new hub centres and 10 to 12 spoke centres; 2 hubs and 6 spokes already commissioned in the current year.
- →Major capex includes INR 30 crores for a state-of-the-art hub facility in JP Nagar, Bangalore, featuring advanced imaging equipment and a central lab.
- →Acquisition of land (~INR 8-10 crores) in a key medical hub in Andhra Pradesh to set up a new state-of-the-art hub centre due to unavailability of leased properties.
- →Setting up a state-of-the-art reference laboratory at Panjagutta included in the overall capex.
- →Focus on expanding dense network model in metro cities and tier-2 locations with enhanced infrastructure and high-end radiology equipment.
💰 Fundraising & Capital Structure
No information- →There is no mention of any current or planned fundraising through debt or equity in the provided transcript.
- →The company maintains a strong balance sheet with a surplus cash position of approximately INR 330 crores.
- →Vijaya Diagnostic Centre emphasizes a disciplined approach to capital allocation and pursues expansions primarily through internal accruals and cash reserves.
- →The capital expenditure of around INR 190 crores for expansion, including new hubs and infrastructure, is planned to be funded from the existing financial strength.
- →No announcements or discussions about raising external funds via debt or equity were made during the call.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Vijaya Diagnost. Q1 FY27 results?
Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets. Vijaya Diagnostic Centre delivered a strong Q1 FY27 with 23% revenue growth and is confident of high double-digit growth for the full year FY27.
What is Vijaya Diagnost. share price analysis?
Vijaya Diagnost. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 82.6 with a market cap of ₹15,495 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vijaya Diagnost. planning capital expenditure?
Planned capex of approximately INR 190 to 195 crores over the next 12 months.
Keep Vijaya Diagnost. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.